Article Details

RedHill Biopharma Further Expands Opaganib Manufacturing Capacity for COVID-19 with Cosmo ...

Retrieved on: 2021-01-28 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

RedHill Biopharma Further Expands Opaganib Manufacturing Capacity for COVID-19 with Cosmo .... View article details on hiswai:

Excerpt

28, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up